FDA 510(k) Premarket Notification — K212561

510(k) Premarket Notification Database · U.S. Food & Drug Administration
K212561
MTX-C1
GEI
Substantially Equivalent (SESE)
08/13/2021
09/27/2022
Traditional
ILOODA Co., Ltd
▼ View Original PDF (3 pages)
FDA 510(k) Notification

510(k) Premarket Notification

Page 1
Page 1
FDA 510(k) PREMARKET NOTIFICATION
Device Classification Name
Electrosurgical, Cutting & Coagulation & Accessories
510(k) Number
K212561
Device Name
MTX-C1
Applicant
ILOODA Co., Ltd
120, Jangan-Ro 458 Beon-Gil, Jangan-Gu
Suwon-Si, KR 16200
Applicant Contact
Yu-Jung Na
Correspondent
Mtech Group
7505 Fannin St. Ste 610
Houston, TX 77054
Correspondent Contact
Dave Kim

Regulatory Details

Regulation Number878.4400
Classification Product CodeGEI
Regulation Medical SpecialtyGeneral & Plastic Surgery
510k Review PanelGeneral & Plastic Surgery

Decision

Date Received08/13/2021
Decision Date09/27/2022
DecisionSubstantially Equivalent (SESE)
SummarySummary
TypeTraditional
Reviewed by Third PartyNo
Combination ProductNo

Page Last Updated: 12/20/2024 — Source: FDA.gov 510(k) Premarket Notification Database

Page 2
Page 2

Page Footer & Navigation

This page contains FDA website navigation links and footer information from the official 510(k) Premarket Notification database printout. The notification record confirms that MTX-C1 (K212561) received a Substantially Equivalent (SESE) determination on September 27, 2022, clearing the device for marketing in the United States.

Page 3
Page 3

Additional References

This page contains additional FDA database cross-reference links, including product classification, CFR search, and the downloadable 510(k) summary PDF (K212561.pdf) hosted on the FDA AccessData portal.